Tracy Morris | Vice President of Corporate Communications & Investor Relations |
Marc Stapley | Chief Executive Officer |
Rebecca Chambers | Chief Financial Officer |
Tina Nova | General Manager of Thyroid & Urologic Cancer |
Giulia Kennedy | Chief Scientific & Medical Officer |
Puneet Souda | SVB Leerink LLC |
Matt Sykes | Goldman Sachs |
Mike Matson | Needham & Company |
Andrew Cooper | CIMB Research |
Good afternoon, ladies and gentlemen, and welcome to Veracyte's Third Quarter 2021 Financial Results Conference Call.
As a reminder, today's conference call is being recorded. I'd now like to turn the conference over to Tracy Morris, Veracyte's Vice President of Corporate Communications and Investor Relations.
You may begin.
Thank you, Erica.